Fabtech Technologies Limited appointed Ms. Bharti Khanna as an Additional Director (Non-Executive & Independent) for a term of five years with immediate effect, subject to shareholder approval. The board also approved the appointment of Mr. Ajaj Abdul Rahiman Kazi as Senior Vice President and Senior Management Personnel. Additionally, the board noted the retirement of Mr. Dilip Ghosh and Mr. Ranganathan Gkseetharaman from their positions as Senior Management Personnel effective May 25, 2026.

The appointments were made based on the recommendations of the Nomination and Remuneration Committee. Ms. Bharti Khanna brings over 30 years of experience in the pharmaceutical industry, with expertise in R&D, regulatory affairs, and strategic project management. Mr. Ajaj Abdul Rahiman Kazi, a certified Project Management Professional (PMP), has over 27 years of experience in MEP project management and business development, previously serving as Head – MEP at Reliance Industries.

The board approved a draft Postal Ballot Notice to seek shareholder approval for the appointment of Ms. Rupal Dhiren Haria and Ms. Bharti Khanna as Non-Executive Independent Directors. The notice will be published and communicated in due course.

Key Appointments and Retirements

Fabtech Technologies Limited delivered robust financial performance in FY26, achieving total income growth of 28.4% year-on-year to ₹431.33 crore despite challenging global macroeconomic conditions. The company's EBITDA increased by 18.29% to ₹55.56 crore, demonstrating resilience in execution capabilities across its international operations spanning over 60 major geographies.

Strong Financial Performance and Balance Sheet Transformation

The company's financial metrics showed substantial improvement across key parameters during FY26:

A strategic equity infusion of approximately ₹230 crore fundamentally strengthened the company's balance sheet, positioning it for future expansion. The company achieved cash flow positive status, turning from negative ₹36 crore to positive ₹50 lakh, while reducing current borrowings from ₹54 crore to ₹42 crore.

Geographic Revenue Distribution and Market Expansion

The company's global business operations showed strong performance across key markets, with UAE emerging as the largest contributor:

The company's expansion strategy focuses on GCC localization through subsidiaries and joint ventures, including 100% subsidiaries in UAE and Saudi Arabia, 33.33% stake in Mark Maker for process equipment, and strategic partnerships across pharmaceutical emerging markets.

Q4 FY26 Performance Highlights

The fourth quarter demonstrated particularly strong execution with total income reaching ₹168.24 crore, representing 22% year-on-year growth. Quarterly net profit rebounded to ₹22.06 crore, reflecting improved operational strength and providing momentum entering the new fiscal year.

Order Book and Project Pipeline

Fabtech Technologies maintains a robust order book exceeding ₹900 crore, providing revenue visibility for 18-24 months. The company has successfully increased project ticket sizes from earlier $30-40 million to current orders worth $70 million, focusing on end-to-end turnkey solutions.

Recent project wins include:

Strategic Outlook and Growth Projections

Management projects approximately 25% growth for the upcoming period, alongside PAT margin improvement towards 9.9% to 10.5% range. The company's hot lead pipeline includes close to $200 million in active proposals across pharmaceutical, healthcare, and biotech sectors.

The expansion into animal health segments, medical devices, and veterinary vaccines has opened new revenue streams, while the company's integrated design-build model continues to provide competitive advantages in regulatory compliance across WHO, EU-GMP, USFDA, and UKMHRA guidelines.

Operational Challenges and Mitigation

Despite strong revenue growth, the company faced margin pressures due to global supply chain disruptions, with raw material costs increasing by approximately 33% and execution costs rising by 43% due to remobilization requirements amid geopolitical tensions. However, the company's localized presence and variation clauses in contracts helped mitigate these impacts while maintaining client commitments.